Dynavax Technologies Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$129.49 | Buy/Sell | $130.51 | 11.21% | 11 | $327.97B |
| PFE | Pfizer | Outperform |
2
|
$28.88 | Buy/Sell | $32.87 | 5.61% | 6 | $163.65B |
| SAN | Sanofi | Outperform |
16
|
89.52€ | Buy/Sell | 102.80€ | 21.76% | 9 | 111.91€B |
| GSK | GSK | Outperform |
12
|
£17.75 | Buy/Sell | £17.30 | 12.39% | 12 | £72.36B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$65.68 | Buy/Sell | $87.82 | 21.80% | 14 | $81.83B |
| MRNA | Moderna | Outperform |
16
|
$166.61 | Buy/Sell | $135.42 | -24.37% | 1 | $63.85B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | Buy/Sell | ¥4.74k | 8.85% | 0 | ¥6.49T |
| BNTX | BioNTech | Outperform |
12
|
$96.95 | Buy/Sell | $123.75 | -3.51% | 3 | $23.40B |
| NVAX | Novavax | Outperform |
11
|
$15.50 | Buy/Sell | $23.25 | 22.58% | 4 | $623.13M |
| VBIV | VBI Vaccines | Outperform |
10
|
$0.65 | Buy/Sell | $6.00 | 669.23% | 0 | $18.63M |